Frost & Sullivan

MARCH 28, 2025

Download our full analysis on the top 6 growth opportunities in pharma and biotech. By 2030, the RLT market is projected to reach $13.07 billion by 2030. The post Pharma & Biotech in 2025: The Top 6 Growth Opportunities Shaping the Future appeared first on Frost & Sullivan. Want deeper insights?

Biotech 52

Biotech Biotechnology Strategic partnership Insurance 52

Frost & Sullivan

MARCH 26, 2025

As agrochemical companies embrace biotech innovations and AI-driven solutions, the market is witnessing a shift toward more efficient, sustainable, and high-performance agricultural inputs. The integration of biotech in agrochemicals enables the development of resilient crops, while AI-powered analytics enhance precision farming techniques.

Biotech 52

Biotech Mergers and acquisition activities Collaboration 52

Frost & Sullivan

APRIL 14, 2025

By 2030, the sector is projected to generate an additional $3 billion in revenue. Internal Challenges Corporate Cultural Shift to Embrace Rapid Biotech Innovation Adapting to fast-paced biotech advances requires an organizational culture that fosters agility, experimentation, and cross-disciplinary collaboration.

Biotech 52

Biotech Engineering Ecosystems Collaboration 52

Frost & Sullivan

MARCH 5, 2025

Middle East: Vision 2030 is driving generative design adoption in real estate and infrastructure. Investment Outlook: Biohybrid technologies will see strong adoption in biotech, environmental science, and smart wearables. Regional Insights: APAC: South Korean startups like PAENE Biotech are pioneering mitochondrial-targeted therapies.

Biotech 52

Biotech Energy Fintech Construction 52

Frost & Sullivan

FEBRUARY 20, 2025

Middle East: Vision 2030 & Net Zero 2050 are pushing Emirates, Qatar Airways, and Etihad to lead global SAF adoption. APAC: Expected to account for 40% of global SAF demand by 2030 , with Nestes Singapore plant leading production. Leverage strategic partnerships in clean energy, biotech, and smart infrastructure.

Biotech 52

Biotech Energy Banking Government 52

Frost & Sullivan

MARCH 13, 2025

Organizations that integrate digital health solutions, AI analytics, and robotic-assisted surgical technologies will be best positioned for success in 2030 and beyond. Click here to download How can digital transformation in surgery address current healthcare challenges and improve patient outcomes? Want deeper insights?

Biotech 52

Biotech Utilities Strategic partnership Ecosystems 52

Frost & Sullivan

MARCH 28, 2025

million by 2030, emphasizing the need for early and accurate diagnostics. Download our full analysis on Cardiac Biomarkers Diagnostics. Click here to download According to the World Health Organization (WHO), CVD-related deaths are projected to reach 23.3 Elabscience Biotechnology, Inc., Quanterix, Response Biomedical Corp.,

Biotechnology 52

Biotechnology Biotech Ecosystems 52